Download PDF
CC BY-NC-ND 4.0 · Neurology International Open 2018; 2(02): E124-E130
DOI: 10.1055/a-0559-2746
Review
Eigentümer und Copyright ©Georg Thieme Verlag KG 2018

Thymectomy in Myasthenia Gravis

Jens C. Rückert
1   Kompetenzzentrum für Thoraxchirurgie (CCM,CVK,CBF), Chirurgische Klinik Campus Charité Mitte / Campus Virchow-Klinikum; Charité – Universitätsmedizin Berlin
,
Marc Swierzy
1   Kompetenzzentrum für Thoraxchirurgie (CCM,CVK,CBF), Chirurgische Klinik Campus Charité Mitte / Campus Virchow-Klinikum; Charité – Universitätsmedizin Berlin
,
Siegfried Kohler
2   Integriertes Myasthenie Zentrum, Klinik für Neurologie, NeuroCure Clinical Research Center, Charité –Universitätsmedizin Berlin
,
Andreas Meisel
2   Integriertes Myasthenie Zentrum, Klinik für Neurologie, NeuroCure Clinical Research Center, Charité –Universitätsmedizin Berlin
,
Mahmoud Ismail
1   Kompetenzzentrum für Thoraxchirurgie (CCM,CVK,CBF), Chirurgische Klinik Campus Charité Mitte / Campus Virchow-Klinikum; Charité – Universitätsmedizin Berlin
› Author Affiliations
Further Information

Publication History

Publication Date:
03 May 2018 (online)

   Permissions and Reprints

Abstract

In recent years much progress has been made in the investigation of the pathophysiology, characterizing subgroups, and extension of multimodal treatment of myasthenia gravis (MG). This applies especially to the role of thymectomy (Thx). Thymectomy is always indicated for thymoma-associated myasthenia gravis. Furthermore, based on large cohort studies, during recent decades thymectomy has also become a central part of immune-modulating MG therapy in patients without thymoma. The lack of randomized studies, however, caused a certain persistent reluctance as to the significance of thymectomy. The current MGTX trial has shown the effectiveness of thymectomy. A significant improvement of myasthenic complaints and the reduction of immunosuppressive medication was primarily shown for acquired early-onset MG (EOMG) with complete resection of all thymic tissue. Because the MGTX study only included patients younger than 65 years with generalized MG and positive for acetylcholine-receptor antibodies, at present the significance of Thx for other relevant subgroups as juvenile MG, MG in older patients, ocular MG, as well as seronegative patients is under investigation. Even the prevailing opinion of no benefit of thymectomy for MuSk-positive patients probably needs reevaluation based on ambiguous findings. With respect to surgery, based on the exclusive performance of extended median sternotomy for MG in the MGTX, the value of thoracoscopic modifications for thymectomy as a minimally-invasive alternative is currently under evaluation. For clinical reasons further judgment regarding different minimally-invasive thymectomy techniques compared to the conventional open procedures in the form of randomized comparative studies would be required. Currently, however, an experience-based robotic-assisted thoracoscopic unilateral approach to thymectomy meets all requirements related to surgical, clinical-neurological and patient aspects. Ethical reasons, therefore, will lead to other strategies for comparison of different surgical techniques.

Key words

Thymectomy - robotic - thoracoscopic - sternotomy - Myasthenia gravis - thymoma
 

  • References

  • 1 Wolfe GI, Kaminski HJ, Aban IB. et al. Randomized trial of thymectomy inmyasthenia gravis. N Engl J Med 2016; 375: 511-522
    CrossrefPubMedGoogle Scholar
  • 2 Schumacher ED, Roth J. Thymektomie bei einem Fall von Morbus Basedowi mit Myasthenie. Mitt Grenzgeb Med Chir 1912; 25: 746 -765
    PubMedGoogle Scholar
  • 3 Laqueur L, Weigert C. Beiträge zur Lehre von der Erbʼschen Krankheit. Neurol Zbl 1901; 20: 4
    PubMedGoogle Scholar
  • 4 Blalock A, Mason MF, Morgan HJ. et al. Myasthenia gravis and tumors of the thymic region: Report of a case in which the tumor was removed. Ann Surg 1939; 110: 544 - 561
    CrossrefPubMedGoogle Scholar
  • 5 Blalock A. Thymectomy in the treatment of myasthenia: Report of 20 cases. J Thorac Surg 1944; 13: 316 - 336
    PubMedGoogle Scholar
  • 6 Blalock A, McGehee H, Ford FR. et al. The treatment of myasthenia gravis (by) removal of the thymus gland: Preliminary report. JAMA 1941; 117: 1529 - 1533
    CrossrefPubMedGoogle Scholar
  • 7 Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001; 357: 2122 - 2128
    CrossrefPubMedGoogle Scholar
  • 8 Gilhus NE, Verschuuren JJ. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol 2015; 14: 1023 - 1036
    CrossrefPubMedGoogle Scholar
  • 9 Sieb JP. Myasthenia gravis: An update for the clinician. Clin Exp Immunol 2013; 175: 10
    PubMedGoogle Scholar
  • 10 Keynes G. The results of thymectomy in myasthenia gravis. Br Med J 1949; 2: 611 - 616
    CrossrefPubMedGoogle Scholar
  • 11 Shrager JB, Nathan D, Brinster CJ. et al. Outcomes after 151 extended transcervical thymectomies for myasthenia gravis. Ann Thorac Surg 2006; 82: 1863 - 1869
    CrossrefPubMedGoogle Scholar
  • 12 Jaretzki 3rd A, Penn AS, Younger DS. et al. “Maximal” thymectomy for myasthenia gravis. Results. J Thorac Cardiovasc Surg 1988; 95: 747 -757
    CrossrefPubMedGoogle Scholar
  • 13 Jaretzki 3rd A. Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy in non-thymomatous myasthenia gravis patients. J Neurol Sci 2004; 217: 233-234 Author reply 235-236
    CrossrefPubMedGoogle Scholar
  • 14 Tomulescu V, Sgarbura O, Stanescu C. et al. Ten-year results of thoracoscopic unilateral extended thymectomy performed in nonthymomatous myasthenia gravis. Ann Surg 2011; 254: 761-765 Discussion 765–766
    CrossrefPubMedGoogle Scholar
  • 15 Bulkley GB, Bass KN, Stephenson GR. et al. Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Ann Surg 1997; 226: 324-334 Discussion 334-325
    CrossrefPubMedGoogle Scholar
  • 16 Gronseth GS, Barohn RJ. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55: 7-15
    CrossrefPubMedGoogle Scholar
  • 17 Sieb JP. Myasthenia gravis: An update for the clinician. Clin Exp Immunol 2014; 175: 408 - 418
    CrossrefPubMedGoogle Scholar
  • 18 Sonett JR, Magee MJ, Gorenstein L. Thymectomy and myasthenia gravis: A history of surgical passion and scientific excellence. J Thorac Cardiovasc Surg 2017; 154: 306 - 309
    CrossrefPubMedGoogle Scholar
  • 19 Kark AE, Kirschner PA. Total thymectomy by the transcervical approach. Br J Surg 1971; 58: 321 - 326
    CrossrefPubMedGoogle Scholar
  • 20 Cooper JD, Al-Jilaihawa AN, Pearson FG. et al. An improved technique to facilitate transcervical thymectomy for myasthenia gravis. Ann Thorac Surg 1988; 45: 242 - 247
    CrossrefPubMedGoogle Scholar
  • 21 Jaretzki 3rd A. Thymectomy for myasthenia gravis: Analysis of controversies regarding technique and results. Neurology 1997; 48 (Suppl. 05): 52S - 63S doi: https://doi.org/10.1212/WNL.48Suppl_ 5.52S
    CrossrefPubMedGoogle Scholar
  • 22 Hermes HM, Cohen GA, Mehrotra AK. et al. Association of thymectomy with infection following congenital heart surgery. World J Pediatr Congenit Heart Surg 2011; 2: 351 - 358
    CrossrefPubMedGoogle Scholar
  • 23 Gui M, Luo X, Lin J. et al. Long-term outcome of 424 childhood-onset myasthenia gravis patients. J Neurol 2015; 262: 823 - 830
    CrossrefPubMedGoogle Scholar
  • 24 Madenci AL, Li GZ, Weil BR. et al. The role of thymectomy in the treatment of juvenile myasthenia gravis: A systematic review. Pediatr Surg Int 2017; 33: 683 - 694
    CrossrefPubMedGoogle Scholar
  • 25 Della Marina A, Kolbel H, Mullers M. et al Outcome after robotic-assisted thymectomy in children and adolescents with acetylcholine receptor antibody-positive juvenile myasthenia gravis. Neuropediatrics 2017; 48: 315 - 322
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Binks S, Vincent A, Palace J. Myasthenia gravis: A clinical-immunological update. J Neurol 2016; 263: 826 - 834
    CrossrefPubMedGoogle Scholar
  • 27 Kawaguchi N, Kuwabara S, Nemoto Y. et al. Effects of thymectomy on late-onset myasthenia gravis without thymoma. Clin Neurol Neurosurg 2007; 109: 858 - 861
    CrossrefPubMedGoogle Scholar
  • 28 Skeie GO, Apostolski S, Evoli A. et al. Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol 2010; 17: 893 - 902
    CrossrefPubMedGoogle Scholar
  • 29 Grob D, Brunner N, Namba T. et al. Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37: 141-149
    CrossrefPubMedGoogle Scholar
  • 30 Schumm F, Dichgans J. [Clinical evaluation system (score) of ocular symptoms in myasthenia gravis]. Nervenarzt 1985; 56: 186 - 187
    PubMedGoogle Scholar
  • 31 Tansel T, Onursal E, Barlas S. et al. Results of surgical treatment for nonthymomatous myasthenia gravis. Surg Today 2003; 33: 666 - 670
    CrossrefPubMedGoogle Scholar
  • 32 Luo LQ, Zhang JZ, Cui HN. Clinical analysis of thymectomy for juvenile with myasthenia gravis. China J Mod Med 2008; 15: 2
    PubMedGoogle Scholar
  • 33 Xie SP, Huang J. A clinical assessment of thymectomy for the treatment of ocular myasthenia gravis in children. J Clin Surg 2010; 18: 2
    PubMedGoogle Scholar
  • 34 Lui Z, Feng H, Yeung SC. et al. Extended transsternal thymectomy for the treatment of ocular myasthenia gravis. Ann Thorac Surg 2011; 92: 7
    CrossrefPubMedGoogle Scholar
  • 35 Zhu K, Li J, Huang X. et al. Thymectomy is a beneficial therapy for patients with non-thymomatous ocular myasthenia gravis: A systematic review and meta-analysis. Neurol Sci 2017; 38: 1753 - 1760
    CrossrefPubMedGoogle Scholar
  • 36 Lauriola L, Ranelletti F, Maggiano N. et al. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 2005; 64: 536 - 538
    CrossrefPubMedGoogle Scholar
  • 37 Leite MI, Strobel P, Jones M. et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 2005; 57: 444-448
    CrossrefPubMedGoogle Scholar
  • 38 Ponseti JM, Caritg N, Gamez J. et al. A comparison of long-term postthymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis. Expert Opin Biol Ther 2009; 9: 1 - 8
    CrossrefPubMedGoogle Scholar
  • 39 Gilhus NE, Skeie GO, Romi F. et al. Myasthenia gravis – autoantibody characteristics and their implications for therapy. Nat Rev Neurol 2016; 12: 259 - 268
    CrossrefPubMedGoogle Scholar
  • 40 Wright CD. Management of thymomas. Crit Rev Oncol Hematol 2008; 65: 109 - 120
    CrossrefPubMedGoogle Scholar
  • 41 Marulli G, Rea F, Melfi F. et al. Robot-aided thoracoscopic thymectomy for early-stage thymoma: A multicenter European study. J Thorac Cardiovasc Surg 2012; 144: 1125 - 1130
    CrossrefPubMedGoogle Scholar
  • 42 Marulli G, Maessen J, Melfi F. et al. Multi-institutional European experience of robotic thymectomy for thymoma. Ann Cardiothorac Surg 2016; 5: 18 - 25
    PubMedGoogle Scholar
  • 43 Fukuhara M, Higuchi M, Owada Y. et al. Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports. J Thorac Dis 2017; 9: 1592-1597
    CrossrefPubMedGoogle Scholar
  • 44 Keijzers M, Dingemans AM, Blaauwgeers H. et al. 8 yearsʼ experience with robotic thymectomy for thymomas. Surg Endosc 2014; 28: 1202 - 1208
    CrossrefPubMedGoogle Scholar
  • 45 Kang CH, Hwang Y, Lee HJ. et al. Robotic thymectomy in anterior mediastinal mass: Propensity score matching study with transsternal thymectomy. Ann Thorac Surg 2016; 102: 895-901
    CrossrefPubMedGoogle Scholar
  • 46 Kneuertz PJ, Kamel MK, Stiles BM. et al. Robotic thymectomy is feasible for large thymomas: a propensity-matched comparison. Ann Thorac Surg 2017; 104: 1673-1678
    CrossrefPubMedGoogle Scholar
  • 47 Liu XD, Shao MR, Sun L et al. Influence of body mass index on postoperative complications after thymectomy in myasthenia gravis patients. 2017; www.impactjournals.com/oncotarget/
    PubMed
  • 48 Gellert K. Die thorakoskopische Thymektomie. Akt Neurol 1998; 25: 570- 572
    PubMedGoogle Scholar
  • 49 Ruckert JC, Gellert K, Einhaupl K. et al. [Thoracoscopic thymectomy for treatment of myasthenia gravis]. Zentralbl Chir 1998; 123: 506- 511
    PubMedGoogle Scholar
  • 50 Mineo TC, Pompeo E, Ambrogi V. et al. Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis. Ann Thorac Surg 1996; 62: 1210 - 1212
    CrossrefPubMedGoogle Scholar
  • 51 Ruckert JC, Gellert K, Muller JM. Operative technique for thoracoscopic thymectomy. Surg Endosc 1999; 13: 943 - 946
    CrossrefPubMedGoogle Scholar
  • 52 Landreneau RJ, Dowling RD, Castillo WM. et al. Thoracoscopic resection of an anterior mediastinal tumor. Ann Thorac Surg 1992; 54: 142 - 144
    CrossrefPubMedGoogle Scholar
  • 53 Mack MJ, Landreneau RJ, Yim AP. et al. Results of video-assisted thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 1996; 112: 1352-1359 Discussion 1359–1360
    CrossrefPubMedGoogle Scholar
  • 54 Brenna G, Antozzi C, Montomoli C. et al. A propensity score analysis for comparison of T-3b and VATET in myasthenia gravis. Neurology 2017; 89: 189 - 195
    CrossrefPubMedGoogle Scholar
  • 55 Ruckert JC, Ismail M, Badakhshi H. et al. [Thymectomy in myasthenia and/or thymoma]. Zentralbl Chir 2014; 139: 121-132 quiz 133–124
    Article in Thieme ConnectPubMedGoogle Scholar
  • 56 Ismail M, Swierzy M, Ruckert JC. State of the art of robotic thymectomy. World J Surg 2013; 37: 2740-2746
    CrossrefPubMedGoogle Scholar
  • 57 Ismail M, Swierzy M, Ruckert RI. et al. Robotic thymectomy for myasthenia gravis. Thorac Surg Clin 2014; 24: 189-195 vi-vii
    CrossrefPubMedGoogle Scholar
  • 58 Marulli G, Schiavon M, Perissinotto E. et al. Surgical and neurologic outcomes after robotic thymectomy in 100 consecutive patients with myasthenia gravis. J Thorac Cardiovasc Surg 2013; 145: 730-735 discussion 735–736
    CrossrefPubMedGoogle Scholar
  • 59 Ruckert JC, Swierzy M, Ismail M. Comparison of robotic and nonrobotic thoracoscopic thymectomy: A cohort study. J Thorac Cardiovasc Surg 2011; 141: 673 - 677
    CrossrefPubMedGoogle Scholar
  • 60 Kawaguchi K, Fukui T, Nakamura S. et al. A bilateral approach to extended thymectomy using the da Vinci Surgical System for patients with myasthenia gravis. Surg Today 2018; 48: 195- 199
    CrossrefPubMedGoogle Scholar
  • 61 Rückert JC, Swierzy M, Rückert RI. et al. Thymectomy (VATS, da Vinci). In: Dienemann HC, Hoffmann H, Detterbeck FC. (eds). Chest Surgery: Springer Surgery Atlas Series. Springer; 2014
    Google Scholar
  • 62 Ismail M, Swierzy M, Rückert RI. et al. Robotic thymectomy for myasthenia gravis. Thorac Surg Clin 2014; 24: 189-195
    CrossrefPubMedGoogle Scholar
  • 63 Elsayed HH, Gamal M, Raslan S. et al. Video-assisted thoracoscopic thymectomy for non-thymomatous myasthenia gravis: a right-sided or left-sided approach?. Interact Cardiovasc Thorac Surg 2017; 25: 651-653
    CrossrefPubMedGoogle Scholar